Surgery Partners, Inc. (NASDAQ: SGRY) had its "outperform" rating re-affirmed by analysts at Macquarie. They now have a $35.00 price target on the stock.
LowReport
Surgery Partners, Inc. (NASDAQ: SGRY) had its "outperform" rating re-affirmed by analysts at Macquarie. They now have a $35.00 price target on the stock.
U.S. Gastroenterology Ambulatory Surgery Centers Market Report 2024-2030 - Corporation-Ownership is Expected to Grow at a CAGR of 5.4% [Yahoo! Finance]
MediumReport
U.S. Gastroenterology Ambulatory Surgery Centers Market Report 2024-2030 - Corporation-Ownership is Expected to Grow at a CAGR of 5.4% [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: